Clinical Trial Update: Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies [Phase 3]

View source ↗

Summary

This clinical trial update covers Expanded Access of Omidubicel for allogeneic transplantation in patients with hematologic malignancies in a Phase 3 study that…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Omidubicel

Snippet

Sponsor: Gamida Cell ltd | Conditions: Hematological Malignancies | Phase 3 | Status: COMPLETED